Autologous hematopoietic recovery after allogeneic hematopoietic stem cell transplantation: A case-based review

被引：0

作者：

Shi, Xiumin ^{[1
]}

Liu, Xiaoliang ^{[1
]}

Tang, Yang ^{[1
]}

Tan, Yehui ^{[1
]}

Han, Wei ^{[1
]}

Gao, Sujun ^{[1
,2
]}

机构：

[1] First Hosp Jilin Univ, Dept Hematol, Changchun, Peoples R China

[2] 1 Xinmin St, Changchun 130021, Jilin, Peoples R China

来源：

TRANSPLANT IMMUNOLOGY | 2023年 / 81卷

关键词：

Autologous hematopoietic recovery; Allo-HSCT; MAC; Incidence; Prognosis; CHRONIC MYELOGENOUS LEUKEMIA; SEVERE APLASTIC-ANEMIA; GRAFT FAILURE; LYMPHOCYTE INFUSION; REMISSION; RECONSTITUTION; CYCLOPHOSPHAMIDE; REJECTION; BMT; SCT;

D O I：

10.1016/j.trim.2023.101920

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is widely applied for the treatment of hematologic malignancies, but autologous hematopoietic recovery (AR) after allo-HSCT is rare clinically, especially after myeloablative conditioning (MAC). The mechanism of AR remains unclear so far, but the prognosis for most patients is relatively good. Second transplantation is preferred after disease relapse. Starting from a real-life clinical case scenario, herein we reviewed some of the crucial issues of AR in light of recent refinements, and discussed our patients based on the current evidence.

引用

页数：5

共 50 条

[31] CARDIOTOXICITY IN HEMATOPOIETIC STEM CELL TRANSPLANTATION: ARE THERE DIFFERENCES BETWEEN AUTOLOGOUS AND ALLOGENEIC TRANSPLANTATION?
Borrego Asuncion, Borrero
De Sanmames Miguel, Fernandez
Melissa Karina, Torres Ochando
Pinedo Leslie, Gonzalez
Juan Francisco, Lopez Rodriguez
De la Cruz Marcos, Cabezas
Curbelo Alejandro, Morales
Haridian, De la Nuez
Paula, Fernandez-Caldas
Fleitas Cynthia, Acosta
Luisa, Guerra
Maria Del Mar, Perera Alvarez
HAEMATOLOGICA, 2021, 106 (10) : 274 - 275
[32] Autologous and Allogeneic Hematopoietic Stem Cell Transplantation: Single Center Experience
Erbey, F.
Atay, D.
Akcay, A.
Akmuradova, A.
Seferkolli, F.
Ozturk, G.
PEDIATRIC BLOOD & CANCER, 2018, 65 : S247 - S247
[33] Comparison of autologous and allogeneic hematopoietic stem cell transplantation for follicular lymphoma
van Besien, K
Loberiza, FR
Bajorunaite, R
Armitage, JO
Bashey, A
Burns, LJ
Freytes, CO
Gibson, J
Horowitz, MM
Inwards, DJ
Marks, DI
Martino, R
Maziarz, RT
Molina, A
Pavlovsky, S
Pecora, AL
Schouten, HC
Shea, TC
Lazarus, HM
Rizzo, JD
Vose, JM
BLOOD, 2003, 102 (10) : 3521 - 3529
[34] Place of autologous and allogeneic hematopoietic stem cell transplantation in ovarian cancer
Nayl, B.
Cabrespine-Faugeras, A.
Maliki, Y. M.
Bay, J. -O.
BULLETIN DU CANCER, 2009, 96 (12) : 1225 - 1232
[35] The Role of Autologous and Allogeneic Hematopoietic Stem Cell Transplantation for Hodgkin Lymphoma
Holmberg, Leona
Maloney, David G.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2011, 9 (09): : 1060 - 1071
[36] Salvage Allogeneic Hematopoietic Cell Transplantation for Relapsed or Progressive Multiple Myeloma After Autologous Hematopoietic Cell Transplantation
Schneidawind, Dominik
Oehrlein, Katharina
Weisel, Katja C.
Faul, Christoph
Kanz, Lothar
Bethge, Wolfgang A.
BLOOD, 2012, 120 (21)
[37] Allogeneic hematopoietic stem cell transplantation
Faul, C.
ONKOLOGIE, 2012, 35 : 112 - 112
[38] Allogeneic hematopoietic stem cell transplantation
Kai, S
Hara, T
THERAPEUTIC APHERESIS AND DIALYSIS, 2003, 7 (03) : 285 - 291
[39] Clinical strategies to enhance thymic recovery after allogeneic hematopoietic stem cell transplantation
Velardi, Enrico
Dudakov, Jarrod A.
van den Brink, Marcel R. M.
IMMUNOLOGY LETTERS, 2013, 155 (1-2) : 31 - 35
[40] Nephrotic syndrome after autologous hematopoietic stem cell transplantation: a case report
Obrisca, Bogdan
Jurubita, Adriana Roxana
Andronesi, Andreea Gabriella
Gherghiceanu, Mihaela
Ismail, Gener
Mitroi, George
Harza, Mihai Cristian
ROMANIAN JOURNAL OF MORPHOLOGY AND EMBRYOLOGY, 2017, 58 (03): : 1099 - 1102

← 1 2 3 4 5 →